Lauren Davison
Family · Clarinda, IANPI 1285143222
Payments from drug & device makers
Across 100 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$332
- Mylan Specialty L.p.$264
- Novo Nordisk$137
- Bayer$100
- Amgen$87
- Novartis$70
- plus $565 from 19 others
What the payments were for
- Food & beverage$1,556100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $332 |
| Mylan Specialty L.p. | 18 | $264 |
| Novo Nordisk | 10 | $137 |
| Bayer | 7 | $100 |
| Amgen | 6 | $87 |
| Novartis | 5 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Lilly USA, LLC | 4 | $59 |
| Merck | 4 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Viatris Specialty LLC | 3 | $46 |
| Insulet Corporation | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| GSK | 2 | $29 |
| Astellas Pharma US Inc | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Vertex | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$125
How this compares
$1,556 in reported general payments places this provider in the 85th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 44 | $48,732 |
| EliquisApixaban | 34 | $24,168 |
| MounjaroTirzepatide | 17 | $16,825 |
| QuliptaAtogepant | 14 | $15,670 |
| Rosuvastatin Calcium | 95 | $4,776 |
| Tolterodine Tartrate ErTolterodine Tartrate | 29 | $3,347 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,288 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,242 |
| Celecoxib | 14 | $1,542 |
| Sucralfate | 29 | $1,243 |
| Levothyroxine Sodium | 140 | $1,072 |
| Pantoprazole Sodium | 108 | $1,068 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $887 |
| Dutasteride | 13 | $881 |
| Fluticasone Propionate | 58 | $838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus | $137 | $48,73244 claims |
| Lilly USA, LLCMounjaro | $59 | $16,82517 claims |
| AbbVieQulipta | $332 | $15,67014 claims |
| AstraZenecaSymbicort | $13 | $3,28812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,268 family providers in Iowa.
Other family in Clarinda
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.